포렌식 분석 소프트웨어 시장 : 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the forensic analytics software market is expected to increase from USD 3.55 billion in 2025 to USD 3.96 billion in 2026 and reach USD 7.13 billion by 2031, growing at a CAGR of 12.47% over 2026 to 2031.

This report is Segmented by Component (Software, Services), Deployment (Cloud-Based, On-Premises), Application (Healthcare Fraud Detection and Claims Analytics, Clinical Data Forensics and Audit Trail Analysis, and Others), End-User (Hospitals and Healthcare Providers, and Others), and Geography (North America, Europe, Asia-Pacific, and Others). The Market Forecasts are Provided in Value (USD).

Global Forensic Analytics Software Market Trends and Insights

Rising Cybercrime Investigations Across Enterprise and Public-Sector Workflows

Healthcare remained one of the most targeted sectors for cyber incidents in 2024 and 2025, and that pressure kept investigation volumes high across hospitals, insurers, and pharmaceutical operations. HHS reported a record level of large healthcare breaches in 2024, with incidents affecting more than 167 million records, which expanded the need for review tools that can process logs, communications, and clinical records at speed. Each confirmed breach creates follow-on work across evidence preservation, entity resolution, documentation, and legal review, and that directly lifts demand for licensed analytics platforms instead of one-time manual examination. The forensic analytics software market is also being supported by civil litigation after breach events, because healthcare defendants increasingly need defensible software outputs that can stand up in court and in regulatory review. Cellebrite's 2025 survey showed that 68% of investigators did not have enough time to fully review case data, which points to a structural capacity gap rather than a temporary surge in workload. That gap is pushing the forensic analytics software market toward automation features that help teams clear evidence backlogs without weakening audit rigor.

Regulatory Preservation and eDiscovery Requirements

Regulatory oversight of electronic records is widening, and that is making preservation, traceability, and defensible search more central to procurement decisions. Healthcare organizations now need software that can preserve audit trails, maintain evidentiary integrity, and support reviews across clinical, legal, and compliance teams without losing chain-of-custody control. The forensic analytics software market is gaining from this shift because hospitals and pharmaceutical firms are under pressure to manage electronic records in a tamper-evident and reviewable format. Cross-border matters add another layer of complexity, since legal requests, privacy rules, and evidence retention duties often overlap and create operational friction for multinational health systems. Research on cross-border cloud forensics in 2026 noted that the CLOUD Act and GDPR can create conflicting legal duties when providers are asked to produce data across jurisdictions. That tension supports the forensic analytics software market because buyers increasingly favor platforms that can separate preservation, review, and access rights across different legal environments.

High Total Cost of Ownership for Advanced Forensic Platforms

High ownership cost remains a real barrier for mid-sized provider groups, regional insurers, and health systems with limited digital investigation budgets. The forensic analytics software market still leans toward enterprise-grade deployments, and that makes advanced platforms harder to justify before a major breach or compliance event occurs. Cost pressure is not only tied to licensing, because storage, implementation, workflow redesign, and specialist staffing also affect the total decision. That slows conversion in price-sensitive accounts even when the operational case for proactive monitoring is clear. The restraint matters most in the underserved mid-market, where buyers often prefer smaller rollouts, narrower use cases, or delayed purchasing decisions. As a result, the forensic analytics software market gives an edge to vendors that can simplify deployment, shorten time to value, and package healthcare-ready workflows without large up-front commitments.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Mobile, Cloud, and Multi-Source Evidence Volumes
2. AI-Assisted Triage, Entity Resolution, and Link Analysis Adoption
3. Shortage of Court-Certified and Tool-Certified Examiners

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Software held 64.20% of revenue in 2025, and it is also expected to be the fastest-growing component with a 13.81% CAGR through 2031. That position shows that buyers increasingly prefer repeatable platforms over project-heavy services when managing fraud review, compliance monitoring, and clinical evidence analysis. The forensic analytics software market has moved toward configurable engines that can handle alerting, audit review, document preservation, and case management in a single operating layer. This preference is strongest in hospital systems and payer organizations that want recurring updates and policy changes without rebuilding workflows each time regulations shift.

The software lead is also reinforced by product investment from established vendors. Services still matter for complex multi-jurisdiction rollouts, especially when pharmaceutical sites or health systems need tailored operating models. Even so, embedded software capabilities now carry more of the value story, because AI triage, search, and record linking are increasingly sold as native functions rather than separate service work. NIST's 2025 guidance on validation in forensic science also raised expectations for software methods, which supports vendors that can document performance and evidentiary fit with greater discipline.

Cloud-based deployment held 66.50% share in 2025, and cloud is also projected to expand at 13.41% through 2031. That lead shows how strongly buyers value elastic storage, centralized access control, and faster provisioning when evidence volumes spike after an incident or audit request. The forensic analytics software market is seeing cloud adoption rise first among payers and mid-sized providers that want enterprise functionality without building dedicated infrastructure. The model also fits distributed networks, where clinics, health plans, compliance teams, and legal reviewers need controlled access to shared cases.

Cloud growth is supported by the need for faster collaboration across multiple facilities and data sources. User-supplied content noted that SaaS compliance tools have helped some hospital clients reduce workload by as much as 50%, which aligns with the appeal of managed updates and faster deployment cycles. The forensic analytics software market still retains a meaningful on-premises base because some healthcare and pharmaceutical buyers cannot move sensitive records freely across borders or into external environments. In practice, cloud wins on scalability and speed, while on-premises and hybrid designs remain necessary wherever jurisdiction, trial data, or patient record controls are stricter.

Complete Report Scope:

• By Component
  • Software
  • Services
• By Deployment
  • Cloud-Based
  • On-Premises
• By Application
  • Healthcare Fraud Detection and Claims Analytics
  • Clinical Data Forensics and Audit Trail Analysis
  • Electronic Health Record (EHR) Misuse and Access Investigation
  • Pharmaceutical Compliance and Clinical Trial Data Forensics
  • Patient Safety Incident Investigation and Root Cause Analysis
  • Other Applications
• By End-User
  • Hospitals and Healthcare Providers
  • Healthcare Payers
  • Pharmaceutical and Biotechnology Companies
  • Other End-Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 41.78% of the forensic analytics software market size in 2025, keeping the region in the lead. The United States drives most of that position because its healthcare system combines strong breach reporting rules, active fraud enforcement, and a broad installed base of payer integrity programs. The forensic analytics software market in North America also benefits from faster adoption of AI-assisted review tools, and Cellebrite made Genesis generally available first to North American state and local government customers in June 2026. Canada and Mexico remain smaller contributors, but their adoption path is improving as regional integrity efforts move closer to U.S. operating models.

Europe held the second-largest revenue position, with Germany, the United Kingdom, and France forming the core markets. Demand in Europe remains closely tied to privacy, evidentiary control, and localized data handling rather than to pure scale alone. The forensic analytics software market in Europe therefore favors vendors that can support defensible processing within stricter legal environments and under more fragmented jurisdictional rules. Western Europe remains the strongest subregional base, while Central and Eastern European systems are adding demand as health digitization and interoperability obligations expand.

Asia-Pacific is forecasted to record the fastest CAGR at 13.75% through 2031, which makes it the strongest growth geography in the forensic analytics software market. Growth is being driven by national health digitization programs across China, Japan, India, and South Korea, all of which are expanding the volume of clinical and operational data that may later require forensic review. In Japan, Fujita Medical University Hospital used Microsoft Sentinel in a broader digital security transformation, reflecting how large institutions are strengthening log preservation and threat analysis capabilities. Middle East and Africa and South America still represent smaller shares, but health modernization efforts, fraud recovery programs, and cloud-led adoption create a steady long-term pipeline for lower-cost deployments.

1. AccessData Group, Inc.
2. Cado Security Ltd.
3. Cellebrite (Public Safety Solutions)
4. Cellebrite DI Ltd.
5. Cyleron
6. Exterro (FTK and Forensic Toolkit)
7. Exterro, Inc.
8. Guidance Software, Inc.
9. IBM
10. Kroll, LLC
11. LogRhythm, Inc.
12. Magnet Forensics (Axiom)
13. Magnet Forensics Inc.
14. MSAB (Micro Systemation AB)
15. Nuix (Investigations and Analytics)
16. Nuix Limited
17. OpenText (EnCase)
18. OpenText
19. Oxygen Forensics, Inc.
20. Paraben Corporation

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Cybercrime Investigations Across Enterprise and Public-Sector Workflows
  • 4.2.2 Regulatory Preservation and eDiscovery Requirements
  • 4.2.3 Expansion of Mobile, Cloud, and Multi-Source Evidence Volumes
  • 4.2.4 AI-Assisted Triage, Entity Resolution, and Link Analysis Adoption
  • 4.2.5 Encryption by Default Increasing Forensic Complexity and Specialized Tool Demand
  • 4.2.6 Cross-Border Data Residency Constraints Favoring Localized Forensic Workflows
• 4.3 Market Restraints
  • 4.3.1 High Total Cost of Ownership for Advanced Forensic Platforms
  • 4.3.2 Shortage of Court-Certified and Tool-Certified Examiners
  • 4.3.3 Interoperability Gaps Across Evidence Sources and Vendor Ecosystems
  • 4.3.4 Lengthy Validation Cycles for AI-Driven Findings in Legal Proceedings
• 4.4 Supply/Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Component
  • 5.1.1 Software
  • 5.1.2 Services
• 5.2 By Deployment
  • 5.2.1 Cloud-Based
  • 5.2.2 On-Premises
• 5.3 By Application
  • 5.3.1 Healthcare Fraud Detection and Claims Analytics
  • 5.3.2 Clinical Data Forensics and Audit Trail Analysis
  • 5.3.3 Electronic Health Record (EHR) Misuse and Access Investigation
  • 5.3.4 Pharmaceutical Compliance and Clinical Trial Data Forensics
  • 5.3.5 Patient Safety Incident Investigation and Root Cause Analysis
  • 5.3.6 Other Applications
• 5.4 By End-User
  • 5.4.1 Hospitals and Healthcare Providers
  • 5.4.2 Healthcare Payers
  • 5.4.3 Pharmaceutical and Biotechnology Companies
  • 5.4.4 Other End-Users
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
  • 6.3.1 AccessData Group, Inc.
  • 6.3.2 Cado Security Ltd.
  • 6.3.3 Cellebrite (Public Safety Solutions)
  • 6.3.4 Cellebrite DI Ltd.
  • 6.3.5 Cyleron
  • 6.3.6 Exterro (FTK and Forensic Toolkit)
  • 6.3.7 Exterro, Inc.
  • 6.3.8 Guidance Software, Inc.
  • 6.3.9 IBM Corporation
  • 6.3.10 Kroll, LLC
  • 6.3.11 LogRhythm, Inc.
  • 6.3.12 Magnet Forensics (Axiom)
  • 6.3.13 Magnet Forensics Inc.
  • 6.3.14 MSAB (Micro Systemation AB)
  • 6.3.15 Nuix (Investigations and Analytics)
  • 6.3.16 Nuix Limited
  • 6.3.17 OpenText (EnCase)
  • 6.3.18 OpenText Corporation
  • 6.3.19 Oxygen Forensics, Inc.
  • 6.3.20 Paraben Corporation

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment